Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hasty

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Is NHEJ a tumor suppressor or an aging suppressor?Paul Hasty
Journal of Molecular Cell Biology|October 7, 2009
Rapamycin: the cure for all that ailsPaul Hasty
Molecular & Cellular Oncology|April 16, 2021
Trex2 responds to damaged replication forks in diverse waysPaul Hasty
Mechanisms of Ageing and Development|December 22, 2004
The impact of DNA damage, genetic mutation and cellular responses on cancer prevention, longevity and aging: observations in humans and micePaul Hasty
Mutation Research|June 1, 2016
EditorialPaul Hasty
Molecular & Cellular Oncology|July 24, 2015
Chromosomal Rearrangements in Cancer: Detection and potential causal mechanismsPaul Hasty, Cristina Montagna
Science (New York, N.Y.)|April 16, 2002
Aging. Genomic priorities in agingPaul Hasty, Jan Vijg
Aging Cell|November 23, 2005
Aging and p53: getting it straight. A commentary on a recent paper by Gentry and VenkatachalamJan Vijg, Paul Hasty
Biotechniques|March 29, 2003
High-throughput inducible expression of transgenes at the Hprt gene in mouse embryonic stem cellsGreg Donoho, Paul Hasty
Aging Cell|March 25, 2004
Rebuttal to Miller: 'Accelerated aging': a primrose path to insight?'Paul Hasty, Jan Vijg
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Is NHEJ a tumor suppressor or an aging suppressor?Paul Hasty
Journal of Molecular Cell Biology|October 7, 2009
Rapamycin: the cure for all that ailsPaul Hasty
Molecular & Cellular Oncology|April 16, 2021
Trex2 responds to damaged replication forks in diverse waysPaul Hasty
Mechanisms of Ageing and Development|December 22, 2004
The impact of DNA damage, genetic mutation and cellular responses on cancer prevention, longevity and aging: observations in humans and micePaul Hasty
Mutation Research|June 1, 2016
EditorialPaul Hasty
Molecular & Cellular Oncology|July 24, 2015
Chromosomal Rearrangements in Cancer: Detection and potential causal mechanismsPaul Hasty, Cristina Montagna
Science (New York, N.Y.)|April 16, 2002
Aging. Genomic priorities in agingPaul Hasty, Jan Vijg
Aging Cell|November 23, 2005
Aging and p53: getting it straight. A commentary on a recent paper by Gentry and VenkatachalamJan Vijg, Paul Hasty
Biotechniques|March 29, 2003
High-throughput inducible expression of transgenes at the Hprt gene in mouse embryonic stem cellsGreg Donoho, Paul Hasty
Aging Cell|March 25, 2004
Rebuttal to Miller: 'Accelerated aging': a primrose path to insight?'Paul Hasty, Jan Vijg
Pageof 8